Sartorius Stedim Biotech ... (SDMHF)
PNK: SDMHF
· Real-Time Price · USD
216.65
-3.35 (-1.52%)
At close: May 30, 2025, 3:33 PM
Sartorius Stedim Biotech S.A. Cash Flow Statement
Financials in EUR. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 115.4M | 40.9M | 35.5M | 47.6M | 56M | 39.8M | 35.5M | 158.9M | 148.6M | 235.9M | 273.5M | 283.2M | 337.8M | 63.82M | 209.5M | 202.5M | 170.9M |
Depreciation & Amortization | 77.4M | 80.6M | 76.2M | 74.5M | 70.4M | 62.5M | 76.1M | 50.4M | 48.6M | 56.1M | 42.2M | 42.7M | 40.7M | 35.86M | 39.4M | 33.9M | 32.4M |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 900K | n/a | n/a | n/a |
Other Working Capital | -23.3M | 62.5M | 21.6M | -84.2M | -33.3M | 63.7M | -51M | -7.9M | 54.7M | -34.5M | 11.7M | -73.2M | -37.4M | 31.45M | 7.8M | 38.2M | 52.2M |
Other Non-Cash Items | -38.3M | 24.9M | 56.2M | 55M | 63.6M | -32.5M | -13.9M | -81.6M | -39.9M | -39.3M | -114.9M | -87.2M | -107.1M | 101.05M | -5.5M | -44M | 1.9M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -34.7M | 138.5M | 90.6M | 39.2M | -17.3M | 163M | 700K | 18.7M | 8.3M | -33.1M | -55.4M | -160.6M | -102.2M | -38.35M | -77.9M | -28.3M | -1.2M |
Operating Cash Flow | 119.8M | 284.9M | 258.5M | 216.3M | 47.9M | 232.8M | 98.4M | 146.4M | 165.6M | 219.6M | 145.4M | 78.1M | 169.2M | 162.37M | 165.5M | 164.1M | 204M |
Capital Expenditures | -65.3M | -80M | -70.4M | -80.2M | -109.2M | -102.8M | -108.9M | -146.1M | -115.8M | -141.9M | -108.8M | -102.7M | -77.2M | -137.99M | -72.6M | -51.4M | -62M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -2.22B | -22.7M | -87.4M | 5.2M | -475.9M | -1.1M | -43.8M | -2.97M | -138.6M | 100K | -100K |
Purchase of Investments | n/a | -100K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -100K | -70.4M | n/a | n/a | -2.4M | -5.8M | n/a | 87.4M | -11.3M | 100K | -100K | n/a | -137.25M | -71.9M | -52.2M | -62.2M |
Investing Cash Flow | -65.3M | -80.2M | -70.4M | -80.2M | -109.2M | -105.2M | -2.33B | -168.8M | -115.8M | -148M | -584.6M | -103.9M | -121M | -140.23M | -210.5M | -52.2M | -62.3M |
Debt Repayment | -13.7M | -5.4M | -29.8M | -289.3M | -551M | -112.5M | 2.22B | 47.5M | 163.8M | -58.6M | 421.8M | 128.7M | -99.5M | -30.47M | 18.4M | -4.6M | 11.2M |
Common Stock Repurchased | -2M | 600K | 3.1M | -5.9M | n/a | 500K | 1.6M | -1.5M | -600K | 400K | 3.1M | -1.1M | -5.6M | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | -67.1M | n/a | n/a | n/a | n/a | -132.7M | n/a | n/a | -116.1M | n/a | -17K | n/a | n/a | -62.7M |
Other Financial Acitivies | -9.9M | -8.8M | -133.1M | -13.9M | 1.19B | -103.2M | -1.2M | -6.9M | -94M | -47.4M | -900K | -2.8M | -2.4M | -243K | -700K | -1.6M | -1M |
Financial Cash Flow | -25.6M | -11.4M | -159.8M | -376.2M | 639.8M | -110.7M | 2.22B | 39.1M | -63.5M | -105.6M | 424M | 9.8M | -107.5M | -30.71M | 17.7M | -6.2M | -52.5M |
Net Cash Flow | 28.7M | 196.3M | 28.5M | -241M | 578.5M | 17.3M | -10.7M | 16M | -13.1M | -38.4M | -10.6M | -9M | -58.5M | -3.17M | -27.9M | 105.3M | 89.6M |
Free Cash Flow | 54.5M | 204.9M | 188.1M | 136.1M | -61.3M | 130M | -10.5M | 300K | 49.8M | 77.7M | 36.6M | -24.6M | 92M | 24.38M | 92.9M | 112.7M | 142M |